Javascript must be enabled to continue!
Formulation and Evaluation of Colon Targeted Drug Delivery System
View through CrossRef
Purpose:The objective of the present study was to develop colon targeted drug delivery system of Metronidazole using guar gum as the carrier.Methods:Matrix tablets containing various proportions of guar gum were prepared by direct compression technique. Rapidly disintegrating Metronidazole core tablets were prepared and compression coated with guar gum and 20% of microcrystalline cellulose. The tablets were evaluated for hardness, thickness, drug uniformity and subjected to in vitro drug release studies under conditions mimicking mouth to colon transit. Results and Conclusions: The FTIR study indicates no possible interaction between Metronidazole and carriers. The tablets were found within the permissible limits for various physiological parameters. In vitro drug release studies in pH 6.8 phosphate buffer solution containing rat cecal contents have demonstrated the susceptibility of guar gum to the colonic bacterial enzyme action with consequent drug release. The pretreatment of rats orally with 1 ml of 2% w/v aqueous dispersion of guar gum for 7 d induced enzyme specifically acting on guar gum thereby increasing drug release. Dissolution studies were performed in 0.1N HCl for 2 h, in pH 7.4 buffer for 3 h and pH 6.8 up to 24 h. The cumulative percentage of drug release of Metronidazole after 24 h in pH 6.8 phosphatebuffers was found to be 98.51±0.02, 86.69±0.02, 84.55±0.04, 39.31±0.02, 24.60±0.02, 18.85±0.02 for formulation F1, F2, F3, F4, F5 and F6. It can be concluded that formulation F1 is considered a potential formulation for targeting the drug to the colon. The results showed that guar gum protects the drug from being release completely in the physiological environment of stomach and small intestine.©2022iGlobal Research and PublishingFoundation. All rights reserved.
Indo Global Journal of Pharmaceutical Sciences
Title: Formulation and Evaluation of Colon Targeted Drug Delivery System
Description:
Purpose:The objective of the present study was to develop colon targeted drug delivery system of Metronidazole using guar gum as the carrier.
Methods:Matrix tablets containing various proportions of guar gum were prepared by direct compression technique.
Rapidly disintegrating Metronidazole core tablets were prepared and compression coated with guar gum and 20% of microcrystalline cellulose.
The tablets were evaluated for hardness, thickness, drug uniformity and subjected to in vitro drug release studies under conditions mimicking mouth to colon transit.
Results and Conclusions: The FTIR study indicates no possible interaction between Metronidazole and carriers.
The tablets were found within the permissible limits for various physiological parameters.
In vitro drug release studies in pH 6.
8 phosphate buffer solution containing rat cecal contents have demonstrated the susceptibility of guar gum to the colonic bacterial enzyme action with consequent drug release.
The pretreatment of rats orally with 1 ml of 2% w/v aqueous dispersion of guar gum for 7 d induced enzyme specifically acting on guar gum thereby increasing drug release.
Dissolution studies were performed in 0.
1N HCl for 2 h, in pH 7.
4 buffer for 3 h and pH 6.
8 up to 24 h.
The cumulative percentage of drug release of Metronidazole after 24 h in pH 6.
8 phosphatebuffers was found to be 98.
51±0.
02, 86.
69±0.
02, 84.
55±0.
04, 39.
31±0.
02, 24.
60±0.
02, 18.
85±0.
02 for formulation F1, F2, F3, F4, F5 and F6.
It can be concluded that formulation F1 is considered a potential formulation for targeting the drug to the colon.
The results showed that guar gum protects the drug from being release completely in the physiological environment of stomach and small intestine.
©2022iGlobal Research and PublishingFoundation.
All rights reserved.
Related Results
A REVIEW ON DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM
A REVIEW ON DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM
The purpose of this review was to select a promising drug delivery system for colon diseases. This review covers the development of Colon Targeted Drug Delivery System (CTDDS) usin...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND
As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
A Novel Approach: Colon Targeted Drug Delivery System
A Novel Approach: Colon Targeted Drug Delivery System
A considerable attention from the past few years towards the drug delivery system approached a new drug delivery system, which is able to release drugs specifically in the colon in...
Atypical Sigmoid Volvulus in an Adolescent: A Case Report and Literature Review
Atypical Sigmoid Volvulus in an Adolescent: A Case Report and Literature Review
Abstract
Introduction
Sigmoid volvulus is an underrecognized diagnosis with potentially fatal outcomes in adolescents; the current study aims to present an adolescent with mild sym...
Advances in Coordination Compounds for the Drug Delivery System in the Human Circulatory System
Advances in Coordination Compounds for the Drug Delivery System in the Human Circulatory System
<b>Background:</b> Drug delivery is a significant and evolving research area that
relies on accurately quantifying drugs, particularly when developing drug delivery
sys...
FORMULATION, DEVELOPMENT AND EVALUATION OF COLON TARGETED BEADS FOR ANTI-INFLAMMATORY DRUG
FORMULATION, DEVELOPMENT AND EVALUATION OF COLON TARGETED BEADS FOR ANTI-INFLAMMATORY DRUG
Mesalamine is an anti-inflammatory drug used in treatment of Crohn’sdisease and ulcerative-colitis. Since Mesalamine islargely absorbed from the upper intestine, selective delivery...
Mortality and morbidity outcomes in patients with inflammatory bowel disease with colon cancer: A nationwide analysis.
Mortality and morbidity outcomes in patients with inflammatory bowel disease with colon cancer: A nationwide analysis.
e15669
Background:
Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is a chronic condition chara...
Abstract 1590: Robust evolutionary conservation and pair-wise co-mapping of polygenic colon and lung cancer susceptibility loci
Abstract 1590: Robust evolutionary conservation and pair-wise co-mapping of polygenic colon and lung cancer susceptibility loci
Abstract
Comparing chromosomal locations of statistically significant colon and lung cancer susceptibility loci detected by linkage in mouse and rat and by GWAS i...

